MECP2 Back

methyl CpG binding protein 2 (Rett syndrome)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of MECP2
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of mental retardation in females.

Community Annotation of MECP2 Add / Edit MECP2: Annotations

No community annotations yet for MECP2.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

MECP2 is highly significantly mutated in
(none)
MECP2 is significantly mutated in
(none)
MECP2 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for MECP2